Serap Sari

Dr. Serap Sari

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2024 in Psychiatry Research Communications
Verified
Journal Article
Open access
SSSerap Sari
Serap Sari
ACAli Savas Cilli
Ali Savas Cilli

12 October 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMengzhen Li
Mengzhen Li
ATAbdulgani Tatar
Abdulgani Tatar
EGEmre Green
Emre Green
ESEbru Simsek
Ebru Simsek
CKcigdem yuce kahraman
cigdem yuce kahraman
AMAdil Mardinoglu
Adil Mardinoglu
We present a WBT Atlas, comprising 4444 WBT samples across 98 distinct health conditions, enabling systematic exploration of disease-associated transcriptomic signatures. Health condition–specific profiles are characterized across immune, metabolic, and cell-type specific features at the gene, gene module, and pathway levels. By integrating matched plasma proteomics data from 1280 participants across 28 health conditions, we further assess blood RNA–protein relationships and demonstrate their complementary biological roles. By integrating RNA and protein signatures, we develop multi-class classification models that accurately distinguish among a wide range of health conditions, with integrated models consistently outperforming those based on single-omics data alone. The identified RNA and protein signatures are validated across ten independent WBT cohorts and the UK Biobank. Together, the WBT Atlas provides a genome-wide resource that enables translational discovery in precision medicine.

4 April 2024 in Nursing for Women's Health
Verified
Journal Article
Closed access
SSSerap Sari
Serap Sari
ACAli Savas Cilli
Ali Savas Cilli

25 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MCMevra Aydin Cil
Mevra Aydin Cil
NKNEVA KARATAŞ
NEVA KARATAŞ
FOFatma Betul Ozgeris
Fatma Betul Ozgeris
ETEsen Tasgin
Esen Tasgin
SSSerap Sari
Serap Sari
RÖRüveyda Esra ÖZKALAYCI
Rüveyda Esra ÖZKALAYCI
Background: Advanced glycation end products (AGEs) may link diet, systemic inflammation, and cognitive function; however, evidence in healthy young adults is limited. Objective: To examine the associations of dietary AGEs (dAGEs) intake, circulating AGE–RAGE biomarkers, inflammation, and oxidant–antioxidant markers with cognitive performance. Methods: This cross-sectional study included healthy young adults aged 19–26 years. dAGEs intake was estimated independently using a food-frequency questionnaire (FFQ) and a three-day food record (3D-FR). Serum AGEs (sAGEs), soluble RAGE (sRAGE), interleukin-6, tumour necrosis factor-alpha (TNF-α), malondialdehyde, catalase, superoxide dismutase, and glutathione were measured. Cognitive performance was assessed using Digit Span Forward, Backward, and Total scores and Stroop Interference. Separate multivariable linear regression models were adjusted for age, sex, body mass index, and depressive symptoms, with Benjamini–Hochberg false-discovery-rate correction. Covariate-adjusted partial least squares structural equation modelling (PLS-SEM) examined the prespecified AGE–RAGE–inflammation pathways. Results: Neither FFQ-derived nor 3D-FR-derived dAGEs intake was associated with serum AGEs. In the separate regression models, higher sAGEs (β = −0.36, 95% CI −0.54 to −0.16) and TNF-α (β = −0.33, 95% CI −0.53 to −0.13) were associated with poorer Digit Span Backward performance after false-discovery-rate correction. No other cognitive associations remained significant. In PLS-SEM, sAGEs were positively associated with sRAGE (β = 0.505, p < 0.001), and sRAGE was positively associated with inflammation (β = 0.601, p < 0.001). Greater inflammation was associated with poorer Digit Span Backward performance (β = −0.398, 95% CI −0.697 to −0.110, p = 0.009), whereas the direct sRAGE–Digit Span Backward path was not significant. An indirect inverse association between sRAGE and Digit Span Backward through inflammation was supported (β = −0.239, 95% bootstrap CI −0.457 to −0.057). Conclusions: Circulating AGE–RAGE-related and inflammatory activity, rather than estimated dAGEs intake, was associated with selected aspects of cognitive performance in healthy young adults. Longitudinal studies with larger samples are needed to establish temporality and confirm the significance of these associations.

20 October 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
MCMevra Aydin Cil
Mevra Aydin Cil
NKNEVA KARATAŞ
NEVA KARATAŞ
FOFatma Betül Ozgeris
Fatma Betül Ozgeris
ETEsen Tasgin
Esen Tasgin
SSSerap Sari
Serap Sari
RÖRüveyda Esra ÖZKALAYCI
Rüveyda Esra ÖZKALAYCI
Background: Advanced glycation end products (AGEs) may link diet, systemic inflammation, and cognitive function; however, evidence in healthy young adults is limited. Objective: This study aimed to examine the associations of dietary AGE (dAGE) intake, circulating AGE–RAGE biomarkers, inflammation, and oxidant–antioxidant markers with cognitive performance. Methods: This cross-sectional study included healthy young adults aged 19–26 years. dAGE intake was estimated using a food-frequency questionnaire (FFQ) and a three-day food record (3D-FR). Serum AGEs (sAGEs), soluble RAGE (sRAGE), interleukin-6, tumour necrosis factor-alpha (TNF-α), malondialdehyde, catalase, superoxide dismutase, and glutathione were measured. Cognitive performance was assessed using Digit Span Forward, Backward, and Total scores and Stroop Interference. Separate multivariable linear regression models were adjusted for age, sex, body mass index, and Beck Depression Inventory-II scores, with Benjamini–Hochberg false-discovery-rate correction. Covariate-adjusted partial least squares structural equation modelling (PLS-SEM) examined the prespecified sAGE–sRAGE–inflammation pathways. Results: In the correlation analyses, dAGE intake estimated using the FFQ and 3D-FR was not significantly associated with sAGE concentrations (p > 0.05). In the separate regression models, higher sAGEs (β = −0.36, 95% CI −0.54 to −0.16) and TNF-α (β = −0.33, 95% CI −0.53 to −0.13) were associated with poorer Digit Span Backward performance after false-discovery-rate correction. No other cognitive associations remained significant. In PLS-SEM, sAGEs were positively associated with sRAGE (β = 0.505, p < 0.001), and sRAGE was positively associated with inflammation (β = 0.601, p < 0.001). Greater inflammation was associated with poorer Digit Span Backward performance (β = −0.398, 95% CI −0.697 to −0.110, p = 0.009), whereas the direct sRAGE–Digit Span Backward path was not significant. An indirect inverse association between sRAGE and Digit Span Backward through inflammation was supported (β = −0.239, 95% bootstrap CI −0.457 to −0.057). Conclusions: In conclusion, higher circulating sAGEs and TNF-α concentrations were associated with poorer working-memory performance, particularly on Digit Span Backward, in healthy young adults, whereas estimated dAGE intake showed no significant associations with cognitive performance. Longitudinal studies with larger samples are needed to establish temporality and confirm the significance of these associations.